Journal
BRAIN TUMOR PATHOLOGY
Volume 25, Issue 2, Pages 67-72Publisher
SPRINGER JAPAN KK
DOI: 10.1007/s10014-008-0237-5
Keywords
Brain tumor stem cell; Cancer stem cell; CD133; Side population
Categories
Ask authors/readers for more resources
Glioblastoma multiforme (GBM) is one of the most malignant forms of human cancer. Despite intensive treatment, the mean survival of GBM patients remains about 1 year. Recent cancer studies revealed that cancer tissues are pathologically heterogeneous and only a small population of cells has the specific ability to reinitiate cancer. This small cell population is called cancer stem cells (CSCs); in brain tumors these are known as brain tumor stem cells (BTSCs). The identification of BTSCs yielded new insights into chemo-and radioresistance, by which BTSCs can survive selectively and initiate recurrence. Research focused on BTSCs as treatment targets may contribute to the discovery of new therapeutic strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available